Polartechnics moves into Pakistan
Monday, 09 March, 2009
Sydney’s Polartechnics has received another international order for its TruScreen cervical cancer screening technology, this time with Pakistan.
The Pakistani Government has initially ordered 100 units but expects to order more in the future.
TruScreen is a point of care detection device for cervical cancer. Cervical cancer is the fourth most common cancer in Pakistan, which has a female population of more than 85 million.
Last month, Polartechnics signed distribution agreements with major medical companies in Indonesia, Thailand, the Philippines and Sri Lanka.
Polartechnics also produces a self-administered HPV test called CerviScreen under a joint venture with Genera BioSystems and Gribbles Pathology.
Potential biological targets for vascular dementia
Caused by damage to blood vessels in the brain, there is currently no approved treatment for...
Ecopha Biotech announces strategic cross-border model
To commercialise its ecopha.bio technology for a Pongamia-based bioeconomy, Australian company...
Could this 'virus-tearing' plastic film protect hospital equipment?
A thin plastic film that tears apart viruses on contact could help protect high-touch hospital...
